Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Endocrine Surgery
  •  Vascular Surgery
  •  General Surgery
  •  Pediatric Surgery
  •  Gastroenterological Surgery
  •  Orthopaedic Surgery
  •  Breast Surgery
  •  Otolaryngology - Head and Neck Surgery

Abstract

Citation: Clin Surg. 2023;8(1):3629.Research Article | Open Access

PD-L1 (22C3) Expression and Molecular Features of Tubo-Ovarian Carcinomas

Chang J1#, Li P2#, Harada S1, Arend RC3, Diffalha SAL1, Kahn AG1, Mackinnon A1, Pesoli C1, Siegal GP1*,# and Huang X1*,#

1Department of Pathology, The University of Alabama at Birmingham, USA
2School of Nursing, The University of Alabama at Birmingham, USA
3Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, USA
#These authors contributed equally to this work

*Correspondance to: Gene P Siegal 

 PDF  Full Text DOI: 10.25107/2474-1647.3629

Abstract

Introduction: Immune checkpoint inhibitors have been used to treat multiple cancers. Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry (IHC) and Tumor Mutational Burden (TMB) are two of the biomarkers relied upon to select patients for immune therapy. Conventional therapy for tubo-ovarian carcinomas cause significant toxic side effect, therefore, it is necessary to investigate other avenues of treatment such as modulation of the immune environment for benefit as potential targets for these types of cancer. Methods: Of 138 patients diagnosed and treated for tubo-ovarian carcinoma between 2013 and 2021 were identified. We explored several strategies including stromal Tumor-Infiltrating Lymphocyte (sTIL) density, PD-L1 IHC, TMB, and molecular profiling. Results: Our study showed sTIL density is positively associated with both PD-L1 positivity (P=0.0005) and TMB score (Rho=0.20, p=0.042). No significant association was identified between PD-L1 positivity and TMB score. PD-L1 positivity was found to be positively associated with PTEN mutation (p=0.0142). Conclusion: PD-L1 positivity and TMB score should best be considered as independent biomarkers for anti-PD-1/PD-L1 inhibition in tubo-ovarian carcinoma. Clinical significance of positive association between PD-L1 expression and PTEN mutation needs further investigation.

Keywords

Tubo-ovarian carcinoma; sTIL; PD-L1; TMB; PTEN

Cite the article

Chang J, Li P, Harada S, Arend RC, Diffalha SAL, Kahn AG, Mackinnon A, et al. PD-L1 (22C3) Expression and Molecular Features of Tubo-Ovarian Carcinomas. Clin Surg. 2023; 8: 3629..

Search Our Journal

Journal Indexed In

Articles in PubMed

RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers
 PubMed  PMC  PDF  Full Text
Risk Factors for Visual Impairment in an Uninsured Population and the Impact of the Affordable Care Act
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Mouth Opening Retaining Appliance after Coronoidotomy for the Treatment of Trismus: Effects on Pain during Postoperative Training and Maximal Extent of Mouth Opening
 Abstract  PDF  Full Text
The Clinicopathologic Features and Management of Recurrent Thymoma
 Abstract  PDF  Full Text
View More...